Michael Merchant | Scientific Adviser
National Institute for Health and Care Excellence
Dr Michael Merchant is a Scientific Adviser in the Data and Analytics team at NICE. He joined NICE in 2023, to work on Real World Evidence for Clinical Prediction Models and AI predictive technologies for diagnosis and prognosis. This work is in review and will form part of the NICE Real World Evidence Framework. More recently his work has focused on innovative applications of AI to support the process of Health Technology Assessment, as part of NICE's HTA Labs. His background is in academic research in radiation therapy for cancer.
Appearances:
Day 2 - Wednesday 29 October @ 09:00
Keynote Panel: Leveraging new technology for smarter decision-making in Rare Disease drug development and access
-What advancements have been made towards AI, RWE and scientific breakthroughs in rare diseases? e.g. Patient behaviour and trial recruitment, data collection, digital health, mRNA & other platforms, wearables devices etc.
-Are these technologies being used and do they add significant value to the healthcare ecosystem. E.g., to improve the diagnosis pathway, access to care, clinician workload and impact on healthcare system for rare diseases
-Are regulators, HTAs and payers supportive of these advancements, does it help with their decision-making process?
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events